doctor

Emily B. Schroeder, MD, PhD

Emily B Schroeder, MD, PhD is a clinical investigator in the Institute for Health Research. She studied epidemiology at the University of North Carolina at Chapel Hill, and trained in Internal Medicine at Duke University and in Endocrinology at the University of Colorado. Her research interests include diabetes surveillance, microvascular and macrovascular complications of diabetes, chronic kidney disease, and epidemiologic methods.

 

 

Institute for Health Research
10065 E. Harvard Ave. Suite 300
Denver, CO 80231
emily.x.schroeder@kp.org


CURRENT


Blood pressure and progression of diabetic kidney disease. This career development award explores the treatment of blood pressure in the progression of diabetic kidney disease. Funder: NIDDK

SUPREME-DM: Sustaining a learning research network. The SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) Network’s DataLink contains extensive clinical and administrative information on over 1.1 million individuals with diabetes from 11 healthcare systems (2005-2012). This project seeks stakeholder engagement to improve the sustainability of this resource. Funder: AHRQ
.
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in Type 1 Diabetes The objective of this multicenter, double-blind, placebo-controlled randomized clinical trial is to determine whether lowering serum uric acid by means of allopurinol early in the course of kidney disease may be effective in preventing or slowing the decline of renal function in patients with type 1 diabetes. Funder: NIDDK

Cardiovascular benefits and safety of glucose-lowering therapies in adults with diabetes. This project using modern comparative effectiveness statistical approaches, including new user designs and marginal structural modeling with inverse probability weighting and targeted minimal loss-based estimated, to study the cardiovascular benefits and safety of glucose-lowering therapies in adults with diabetes. Funder: NHLBI



COMPLETED


Predicting the risk of end stage renal disease. CESR.

Multi-institutional consortium for CER in diabetes treatment and prevention (SUPREME-DM). AHRQ

Predictors of simultaneous control among patients with diabetes, hypertension, and hyperlipidemia. Endocrine Fellows Foundation


 

Schmittdiel JA, Desai J, Schroeder EB, Paolino AR, Nichols GA, Lawrence JM, O’Connor PJ, Ohnsory KA, Newton KM, Steiner JF. Methods for engaging stakeholders in comparative effectiveness research: a patient-centered approach to improving diabetes care. Healthcare: the Journal of Delivery Science and Innovation. 2015; in press.

Vazquez-Benitez G, Desai JR, Xu S, Goodrich GK, Schroeder EB, Nichols GA, Segal J, Butler MG, Karter AJ, Steiner JF, Newton KM, Morales LS, Pathak RD, Thomas A, Reynolds K, Kirschner HL, Waitzfelder B, Elston Lafata J, Adibhatla R, Xu Z, O’Connor PJ. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis. Diabetes Care, 2015; in press.

Nichols GA, Schroeder EB, Karter AJ, Gregg EW, Desai J, Lawrence JM, O’Connor PJ, Xu S, Newton KM, Raebel MA, Pathak RD, Waitzfelder B, Segal J, Elston Lafata J, Butler MG, Kirschner HL, Thomas A, Steiner JF. Trends in diabetes incidence among 7 million insured adults, 2006-2001: The SUPREME-DM Project. American Journal of Epidemiology. 2015;181(1):32-39.

O'Connor PJ, Schmittdiel JA, Pathak RD, Harris RI, Newton KM, Ohnsorg KA, Heisler M, Sterrett AT, Xu S, Dyer WT, Raebel MA, Thomas A, Schroeder EB, Desai JR, Steiner JF. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. Diabetes Care. 2014 Dec;37(12):3317-24. PubMed PMID: 25315207.

Raebel MA, Ellis JL, Schroeder EB, Xu S, O’Connor PJ, Segal JB, Butler MG, Schmittdiel JA, Kirchner HL, Goodrich GK, Lawrence JM, Nichols GA, Newton KM, Pathak RD, Steiner JF. Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study. Pharmacoepidemiology and Drug Safety. 2014; 23(7):699-710. PMID 24639086.

Xu S, Schroeder EB, Shetterly S, Goodrich GK, O’Connor PJ, Steiner JF, Schmittdiel JA, Desai J, Pathak RD, Neugebauer R, Butler MG, Kirchner L, Raebel MA.  Accuracy of Hemoglobin A1c Imputation using Fasting Plasma Glucose in Diabetes Research using Electronic Health Records Data. Statistics, Optimization & Information Computing. 2014;2:93-104.

Schmittdiel JA, Raebel MA, Dyer W, Xu S, Goodrich GK, Schroeder EB, Segal JB, O’Connor PJ, Nichols GA, Lawrence JM, Kirchner HL, Karter AJ, Lafata JE, Butler MG, Steiner JF.  Prescription Medication Burden in Patients With Newly-Diagnosed Diabetes: A Surveillance, Prevention, and Management of Diabetes Mellitus (SUPREME-DM) Study.  J Am Pharm Assoc. 2014;May 23:e251-e259. [Epub ahead of print]. PMID: 24860866.

Schroeder EB, Bayliss EA, Daugherty SL, Steiner JF. Gender differences in cardiovascular risk factors in incident diabetes. Women’s Health Issues 2014;24(1):e61-e68. PMID: 24439948.

Raebel MA, Xu S, Goodrich GK, Schroeder EB, Schmittdiel JA, Segal JB, O’Connor PJ, Nichols GA, Lawrence JM, Kirchner HL, Elston Lafata J, Bulter M, Netwon KM, Steiner JF. Initial antihyperglycemic drug therapy among 241,327 adults with newly identified diabetes from 2005 through 2010:  a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) Study. Annals of Pharmacotherapy 2013;47(10):1280-91. PMID: 24259692.

Schroeder EB, Hanratty R, Beaty BL, Bayliss EA, Havranek E, Steiner JF. Simultaneous control of diabetes, hypertension, and hyperlipidemia in two health systems. Circulation: Cardiovascular Quality and Outcomes 2012;6:645-653. PMID: 22851534.

Raebel MA, Carroll NM, Ellis JL, Schroeder EB, Bayliss EA. Importance of including early nonadherence in estimations of medication adherence. Annals of Pharmacotherapy 2011;45:1053-60. PMID: 21852598

Raebel MA, Ellis JL, Carroll NM, Bayliss EA, McGinnis B, Schroeder EB, Shetterly S, Xu S, Steiner JF. Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders. Journal of General Internal Medicine 2012:27:57-64.  PMID: 21879374.

Schroeder EB, Welch VL, Evans GW, Heiss G. Impaired lung function and subclinical atherosclerosis: the ARIC study. Atherosclerosis 2005;180:367-73. PMID: 15910864

Schroeder EB, Chambless LE, Liao D, Prineas RJ, Evans GW, Rosamond WD, Heiss G. Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2005;28:668-74. PMID: 15735206

Vaidean GD, Schroeder EB, Whitsel EA, Prineas RJ, Chambless LE, Perhac JS, Heiss G, Rautaharju PM. Short-term repeatability of electrocardiographic spatial T-wave axis and QT interval. Journal of Electrocardiology 2005; 38:139-47. PMID: 15892024

Rosamond WD, Evenson KR, Schroeder EB, Morris DL, Johnson AM, Brice JH. Calling emergency medical services for acute stoke: a study of 9-1-1 tapes. Prehospital Emergency Care 2005;9:19-23. PMID: 16036823

Schroeder EB, Whitsel EA, Evans GW, Prineas RJ, Chambless LE, Heiss G. Repeatability of heart rate variability measures. Journal of Electrocardiology 2004;37:163-72. PMID: 15286929

Schroeder EB, Welch VL, Couper D, Nieto FJ, Liao D, Rosamond WD, Heiss G. Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study.  American Journal of Epidemiology 2003;158:1171-81. PMID: 14652302

Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G. Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Hypertension 2003;42:1106-11. PMID: 14581296

Evenson KR, Schroeder EB, Legare TB, Brice JH, Rosamond WD, Morris DL. A comparison of emergency medical service times for stroke and myocardial infarction. Prehospital Emergency Care 2001;5:335-9. PMID: 11642581

Schroeder EB, Rosamond WD, Morris DL, Evenson KR, Hinn AR. Determinants of use of emergency medical services in a population with stroke symptoms: the Second Delay in Accessing Stroke Healthcare (DASH II) Study.  Stroke 2000;31:2591-6. PMID: 11062280